Monoclonal antibodies against MERS coronavirus show promise in phase 1 trial
A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed...
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19
PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ &...
Promising phase 1 trial results: Use of sotorasib (AMG 510) in patients with solid tumors
A phase 1 clinical trial of sotorasib (AMG 510) in...
Phase III trials of coronavirus vaccine to take place at 5 US military sites, Pentagon confirms
Pentagon confirms Phase III trials of coronavirus ...
Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder
IRVINE, Calif. & BASEL, Switzerland–(BUS...
